Parkinson’s disease is a neurodegenerative disease caused by the loss of neurons that produce dopamine, a neurotransmitter involved in motor control and cognitive function.
Tivdak gets primary endpoint in PhIII confirmatory study
Genmab and Seagen’s cervical cancer drug Tivdak has reached its primary endpoint in a confirmatory Phase III trial, and the results are expected to support